FDA Approves Second Drug in BD Simplist™ Prefilled Injectable Line of Products
April 23, 2013
Franklin Lakes, NJ – BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved the second drug to be offered in the recently launched BD Simplist™ line of ready-to-administer prefilled generic injectables. The second BD [...]
Illumina Reports Strong Start to Fiscal Year 2013
April 23, 2013
AN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the first quarter of 2013. First quarter 2013 results: Revenue of $331 million, a 21% increase compared to $273 million in the first quarter of 2012 GAAP net loss for the quarter of $23 million, or $0.18 per diluted share due to a [...]
Molecular Devices Introduces FLIPR Calcium 6 Assay Kits
April 23, 2013
Sunnyvale, California, – Molecular Devices announced today the launch of FLIPR® Calcium 6 Assay Kits, the latest addition to their extensive range of calcium assay kits to address diversified GPCR and ion channel targets. Featuring a proprietary fluorophore, the dye offers the highest quantum yield of any calcium indicator on the market, delivering the greatest [...]
RainDanceTechnologiesLaunchesNewProgramtoAidProvidersofGeneticTestingServices
April 23, 2013
LEXINGTON, Mass. –– RainDance Technologies, Inc., the Digital Biology™ company, today announced a new Service Partner Program for its growing base of research customers who are developing next-generation sequencing-based genetic testing panels to identify and characterize inherited diseases, cancers and other human health conditions in research projects. Through this new program, customers have expanded access [...]
Integral Molecular Launches MPS Platform for Discovery of Antibodies Targeting Membrane Proteins
April 23, 2013
PHILADELPHIA -- Integral Molecular, Inc., a leader in membrane protein reagents and services, announces the launch of its Membrane Protein Solutions (MPSTM) antibody discovery platform. MPSTM enables the isolation, characterization, and engineering of monoclonal antibodies (MAbs) against difficult membrane protein targets including GPCRs, transporters and ion channels. The technology platform harnesses the strength of Integral’s [...]
April 23, 2013
London, United Kingdom - DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today confirms that it will be continuing the development of a semiconductor sequencing platform after Roche passes its project to DNA Electronics. DNA Electronics now plans to take the project forward, differentiated with a new focus that [...]
April 23, 2013
Biomedical informatics company Aridhia today announced that it is a lead commercial partner alongside Life Technologies Corporation, a global biotechnology tools company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The SMS-IC is a unique collaboration bringing together expertise from within Scottish industry, academia and the NHS to drive forward a new age of stratified [...]
Seegene and Selventa form strategic collaboration to develop novel molecular diagnostics (MoDx)
April 23, 2013
Seoul, South Korea, and Cambridge, Mass., –Seegene and Selventa today announced that they have entered into a strategic collaboration to develop novel molecular diagnostics in underserved diagnostic markets including autoimmune, cancer and infectious diseases. The synergistic combination of Selventa’s Systems Diagnostics (SysDx™) multi-omic analytics platform and Seegene’s TOCE™ and DPO™ multiplex PCR technology will result [...]
Malvern Instruments and NETZSCH Grinding & Dispersing sign agreement to cooperate
April 23, 2013
Materials and biophysical characterization company Malvern Instruments Ltd. (Malvern, UK) and NETZSCH Grinding & Dispersing (headquartered in Selb, Germany), a worldwide manufacturer of industrial wet and dry grinding, mixing, dispersing and kneading equipment, have entered into a cooperative marketing agreement. Both organizations serve a broad range of market sectors from pharmaceuticals, ceramics, nano-technology applications, food [...]
Miltenyi Biotec Acquires Owl biomedical, Inc.
April 23, 2013
SANTA BARBARA, CA and BERGISCH GLADBACH, GERMANY, —Miltenyi Biotec announced today that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems using fully-closed disposable cartridges in an easy-to-use format. The acquisition underscores Miltenyi’s commitment to bringing comprehensive solutions to the research and clinical cell therapy markets. [...]

